Julie E. Riccio, M.D.

Dr. Riccio focuses on patent ductus arteriosus in premature neonates. Her prior work assessed the use of Ibuprofen versus indomethacin for medical treatment of PDA among level 3 NICU's across the United States. She also studied the effect of Ibuprofen, used for closure of the PDA, on bilirubin-albumin binding.

She is now piloting a study with a subset of NRN sites, headed by the Children's Hospital of Philadelphia. This pilot reviews the incidence and natural history of vocal cord injury after PDA ligation in premature infants. Dr. Riccio also serves as a sub-investigator with a study, Noninvasive Optical Brain Imaging of Infants Born Prematurely, for which Lauren Emberson, PhD, and Richard Aslin, PhD, of UR's Department of Brain and Cognitive Sciences, manage follow up activities after discharge.